InvestorsHub Logo

Lurker3

03/16/24 3:28 PM

#183862 RE: walterc #183853


I never said Bioaegis was going to the Nasdaq in 2021 



Alle opties zijn open . Er zullen waarschijnlijk eerst licenties worden verleend en partnerships afgesloten na Juni 2021.; Daarna komt er eventueel een IPO en ook een overname wordt niet uitgesloten

All options are open. Firstly, they will go for licensee and partnerships after 2021. Then an IPO also a buy out isnt ruled out.

Clearly, insinuating that one was on the horizon but its 2024. Btw how are those partnerships and buy out?

Totally disregarding the fact that a clinical phase 2 trial can take between 7-10 years. Especially performed in multiple countries.

Btw, what is the value of bioaegis? Still 5.7 billion?

Lurker3

03/16/24 3:34 PM

#183863 RE: walterc #183853

No doubt that it is your passion and I met you in my early 20's on a trip to belgium and kept sporadically in contact with one of your friends. You dont remember me and I can only recall your face on the pictures

However, you totally miss critical analysis about the companies that you write about.
You are to closed attached to the companies.
Your vision is that you have to have a close relationship with management. In itself that isnt a bad concept if you are still able to be critical when needed.

Well your emails never present a critical thought and that you are wrong about your first analysis of thought.

Therefore, it becomes a bit of a laugh to read how your pov towards your investments.


Oh one more thing niocorp, lwlg and bioaegis arent start ups anymore.

They exist for over 20 years and are estiblished establisments.